Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

JAFMX vs. XLV: which is better?

Bottom line

JAFMX vs XLV: the short answer

JAFMX (Health Sciences Trust) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.

But JAFMX is far broader, holding 173 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.

XLV is cheaper at 0.08% vs 0.99% — a difference of $91 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +4.2% for JAFMX.

Updated Nov 19, 2026

JAFMX vs XLV side by side

JAFMXXLV
TypeMutual fundETF
Fund familyJohn HancockSPDR (State Street)
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.99%0.08%
Annual cost per $10k$99$8
10-yr cost on $10k (prospectus)$1,224$103
Max front load—None
12b-1 fee0%0.02%
1-yr return+19.5%+14.5%
5-yr return (annualized)+4.2%+8.1%
10-yr return (annualized)+8.8%+9.8%
Best quarter—+14.5%
Worst quarter—−12.7%
Net assets (fund)$251.3M$40.6B
Number of holdings17365
Portfolio turnover68%2%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

17 of JAFMX's top 25 holdings also appear in XLV's top 25.

Shared top holdings
HoldingJAFMXXLV
Eli Lilly and Company14.30%16.51%
Johnson and Johnson6.33%10.64%
UnitedHealth Group Incorporated5.95%6.57%
AbbVie Inc.5.28%7.74%
Merck and Co. Inc.4.21%5.52%
Gilead Sciences Inc.2.95%2.73%
Thermo Fisher Scientific Inc.2.67%3.24%
Vertex Pharmaceuticals Incorporated2.38%2.19%
Bristol-Myers Squibb Company2.22%2.05%
Abbott Laboratories2.00%2.75%
Intuitive Surgical Inc.1.98%2.45%
Amgen Inc.1.90%3.40%
Stryker Corporation1.87%1.89%
Elevance Health Inc.1.63%1.46%
Danaher Corporation1.51%2.09%

Source: SEC Form N-PORT

JAFMX top 10

  1. Eli Lilly and Company — 14.30%
  2. Johnson and Johnson — 6.33%
  3. UnitedHealth Group Incorporated — 5.95%
  4. AbbVie Inc. — 5.28%
  5. Merck and Co. Inc. — 4.21%
  6. Gilead Sciences Inc. — 2.95%
  7. Thermo Fisher Scientific Inc. — 2.67%
  8. Vertex Pharmaceuticals Incorporated — 2.38%
  9. Bristol-Myers Squibb Company — 2.22%
  10. Abbott Laboratories — 2.00%

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

FAQ

What is the difference between JAFMX and XLV?
JAFMX (Health Sciences Trust) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds. But JAFMX is far broader, holding 173 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.
Which is cheaper, JAFMX or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both JAFMX and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.